Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITP
NCT04735588 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 140
Last updated 2022-08-26
Summary
Multicenter retrospective and prospective observational study based on the collection of sequential anonymized data from principal Italian ITP centers, to describe the clinical course of ITP patients becoming infected by SARS-CoV-2 and of COVID-19 patients developing de novo ITP.
Conditions
- Immune Thrombocytopenia
- ITP
- Covid19
- ITP Secondary to Infection
Sponsors & Collaborators
-
Gruppo Italiano Malattie EMatologiche dell'Adulto
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-08-22
- Primary Completion
- 2023-06-30
- Completion
- 2024-03-31
Countries
- Italy
Study Locations
More Related Trials
-
Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
NCT00454857 ·Status: COMPLETED
-
Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)
NCT06665308 ·Status: COMPLETED
-
National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients
NCT07268898 ·Status: NOT_YET_RECRUITING
-
Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19)
NCT04516837 ·Status: UNKNOWN ·Phase: PHASE2
-
RDW, Platelet Kinetics and Survival Outcome in Covid-19 Hospitalized Patients.
NCT06755658 ·Status: ACTIVE_NOT_RECRUITING
-
Epidemiology of Thrombotic Thrombocytopenia Syndrome in Integrated Health-care Database in England
NCT05222750 ·Status: COMPLETED
-
Outcome Study of Conventional Steroids Vs. Steroids Combined with Mycopehnolate in Newly Diagnosed Immune Thrombocytopenia Purpura.
NCT06288932 ·Status: COMPLETED ·Phase: PHASE3
-
Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia.
NCT06531018 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Observational Study on the Outcome of Patients With ITP Who Underwent Splenectomy After 2010
NCT06466824 ·Status: NOT_YET_RECRUITING
-
Immunological Markers in Adult Patients With Immune Thrombocytopenic Purpura
NCT04056507 ·Status: COMPLETED
-
Italian iTTP Registry
NCT06376786 ·Status: RECRUITING
-
Prognostic Value of CD Markers in Immune Thrombocytopenic Purpura
NCT04311593 ·Status: UNKNOWN
-
Triple Therapy in Patients With Idiopathic Thrombocytopenic Purpura : What is Behind?
NCT04128358 ·Status: UNKNOWN ·Phase: NA
-
Association of the Risk for Thrombotic Thrombocytopenia Syndrome and Exposure To COVID-19 Vaccines
NCT05252442 ·Status: COMPLETED
-
Immune Thrombocytopenia Management in Adults
NCT05861297 ·Status: UNKNOWN ·Phase: PHASE4
-
Risk Factors for Thrombosis in Immune Thrombocytopenia
NCT03820960 ·Status: COMPLETED
-
Diagnostic Role of Antiphospholipid Antibodies and Microparticles in Immune Thrombocytopenic Patients With Thrombosis
NCT05830916 ·Status: NOT_YET_RECRUITING
-
Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)
NCT01610180 ·Status: COMPLETED ·Phase: PHASE2
-
IL37,Tlymphocytes,NK Cells in Pathogenesis of ITP
NCT04482777 ·Status: UNKNOWN
-
Eltrombopag Plus Diacerein vs Eltrombopag in Adult ITP
NCT04917679 ·Status: COMPLETED ·Phase: PHASE2
-
An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers
NCT00005570 ·Status: COMPLETED
-
Evaluation of the Use of Thrombopoietin Receptor Agonists in Adults With Primary ITP in Europe
NCT06408324 ·Status: COMPLETED
-
This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP)
NCT02859909 ·Status: COMPLETED ·Phase: PHASE3
-
Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis
NCT04800458 ·Status: RECRUITING ·Phase: NA
-
Atorvastatin in Management of Newly Diagnosed ITP
NCT03692754 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3